| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.00065 | 1 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.00092 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.00039 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.00045 | 1 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |